211 related articles for article (PubMed ID: 30902969)
1. Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis.
Kelly MJ; So J; Rogers AJ; Gregory G; Li J; Zethoven M; Gearhart MD; Bardwell VJ; Johnstone RW; Vervoort SJ; Kats LM
Nat Commun; 2019 Mar; 10(1):1347. PubMed ID: 30902969
[TBL] [Abstract][Full Text] [Related]
2. A Non-canonical BCOR-PRC1.1 Complex Represses Differentiation Programs in Human ESCs.
Wang Z; Gearhart MD; Lee YW; Kumar I; Ramazanov B; Zhang Y; Hernandez C; Lu AY; Neuenkirchen N; Deng J; Jin J; Kluger Y; Neubert TA; Bardwell VJ; Ivanova NB
Cell Stem Cell; 2018 Feb; 22(2):235-251.e9. PubMed ID: 29337181
[TBL] [Abstract][Full Text] [Related]
3. KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis.
Isshiki Y; Nakajima-Takagi Y; Oshima M; Aoyama K; Rizk M; Kurosawa S; Saraya A; Kondo T; Sakaida E; Nakaseko C; Yokote K; Koseki H; Iwama A
Blood Adv; 2019 Sep; 3(17):2537-2549. PubMed ID: 31471323
[TBL] [Abstract][Full Text] [Related]
4. BCOR regulates myeloid cell proliferation and differentiation.
Cao Q; Gearhart MD; Gery S; Shojaee S; Yang H; Sun H; Lin DC; Bai JW; Mead M; Zhao Z; Chen Q; Chien WW; Alkan S; Alpermann T; Haferlach T; Müschen M; Bardwell VJ; Koeffler HP
Leukemia; 2016 May; 30(5):1155-65. PubMed ID: 26847029
[TBL] [Abstract][Full Text] [Related]
5. Loss of Asxl2 leads to myeloid malignancies in mice.
Li J; He F; Zhang P; Chen S; Shi H; Sun Y; Guo Y; Yang H; Man N; Greenblatt S; Li Z; Guo Z; Zhou Y; Wang L; Morey L; Williams S; Chen X; Wang QT; Nimer SD; Yu P; Wang QF; Xu M; Yang FC
Nat Commun; 2017 Jun; 8():15456. PubMed ID: 28593990
[TBL] [Abstract][Full Text] [Related]
6. BCOR-coupled H2A monoubiquitination represses a subset of androgen receptor target genes regulating prostate cancer proliferation.
Lempiäinen JK; Manjur ABMK; Malinen M; Ketola K; Niskanen EA; Palvimo JJ
Oncogene; 2020 Mar; 39(11):2391-2407. PubMed ID: 31925334
[TBL] [Abstract][Full Text] [Related]
7. Polycomb repressive complex 1.1 coordinates homeostatic and emergency myelopoiesis.
Nakajima-Takagi Y; Oshima M; Takano J; Koide S; Itokawa N; Uemura S; Yamashita M; Andoh S; Aoyama K; Isshiki Y; Shinoda D; Saraya A; Arai F; Yamaguchi K; Furukawa Y; Koseki H; Ikawa T; Iwama A
Elife; 2023 Jun; 12():. PubMed ID: 37266576
[TBL] [Abstract][Full Text] [Related]
8. Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation.
Nagase R; Inoue D; Pastore A; Fujino T; Hou HA; Yamasaki N; Goyama S; Saika M; Kanai A; Sera Y; Horikawa S; Ota Y; Asada S; Hayashi Y; Kawabata KC; Takeda R; Tien HF; Honda H; Abdel-Wahab O; Kitamura T
J Exp Med; 2018 Jun; 215(6):1729-1747. PubMed ID: 29643185
[No Abstract] [Full Text] [Related]
9.
Tara S; Isshiki Y; Nakajima-Takagi Y; Oshima M; Aoyama K; Tanaka T; Shinoda D; Koide S; Saraya A; Miyagi S; Manabe I; Matsui H; Koseki H; Bardwell VJ; Iwama A
Blood; 2018 Dec; 132(23):2470-2483. PubMed ID: 30228234
[No Abstract] [Full Text] [Related]
10. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.
Abdel-Wahab O; Adli M; LaFave LM; Gao J; Hricik T; Shih AH; Pandey S; Patel JP; Chung YR; Koche R; Perna F; Zhao X; Taylor JE; Park CY; Carroll M; Melnick A; Nimer SD; Jaffe JD; Aifantis I; Bernstein BE; Levine RL
Cancer Cell; 2012 Aug; 22(2):180-93. PubMed ID: 22897849
[TBL] [Abstract][Full Text] [Related]
11. Clarifying the impact of polycomb complex component disruption in human cancers.
Yamamoto Y; Abe A; Emi N
Mol Cancer Res; 2014 Apr; 12(4):479-84. PubMed ID: 24515802
[TBL] [Abstract][Full Text] [Related]
12. Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis.
Chang YI; You X; Kong G; Ranheim EA; Wang J; Du J; Liu Y; Zhou Y; Ryu MJ; Zhang J
Leukemia; 2015 Sep; 29(9):1847-56. PubMed ID: 25801914
[TBL] [Abstract][Full Text] [Related]
13. A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies.
Bahr C; von Paleske L; Uslu VV; Remeseiro S; Takayama N; Ng SW; Murison A; Langenfeld K; Petretich M; Scognamiglio R; Zeisberger P; Benk AS; Amit I; Zandstra PW; Lupien M; Dick JE; Trumpp A; Spitz F
Nature; 2018 Jan; 553(7689):515-520. PubMed ID: 29342133
[TBL] [Abstract][Full Text] [Related]
14. BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes.
Schaefer EJ; Wang HC; Karp HQ; Meyer CA; Cejas P; Gearhart MD; Adelman ER; Fares I; Apffel A; Lim K; Xie Y; Gibson CJ; Schenone M; Murdock HM; Wang ES; Gondek LP; Carroll MP; Vedula RS; Winer ES; Garcia JS; Stone RM; Luskin MR; Carr SA; Long HW; Bardwell VJ; Figueroa ME; Lindsley RC
Blood Cancer Discov; 2022 Mar; 3(2):116-135. PubMed ID: 35015684
[TBL] [Abstract][Full Text] [Related]
15. Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis.
Asada S; Goyama S; Inoue D; Shikata S; Takeda R; Fukushima T; Yonezawa T; Fujino T; Hayashi Y; Kawabata KC; Fukuyama T; Tanaka Y; Yokoyama A; Yamazaki S; Kozuka-Hata H; Oyama M; Kojima S; Kawazu M; Mano H; Kitamura T
Nat Commun; 2018 Jul; 9(1):2733. PubMed ID: 30013160
[TBL] [Abstract][Full Text] [Related]
16. Loss of function mutations of
Giefing M; Gearhart MD; Schneider M; Overbeck B; Klapper W; Hartmann S; Ustaszewski A; Weniger MA; Wiehle L; Hansmann ML; Melnick A; Béguelin W; Sundström C; Küppers R; Bardwell VJ; Siebert R
Leuk Lymphoma; 2022 May; 63(5):1080-1090. PubMed ID: 34957890
[TBL] [Abstract][Full Text] [Related]
17. The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma.
Kang JH; Lee SH; Lee J; Choi M; Cho J; Kim SJ; Kim WS; Ko YH; Yoo HY
BMC Cancer; 2021 Jan; 21(1):82. PubMed ID: 33468080
[TBL] [Abstract][Full Text] [Related]
18. Age-Related Co-Expression of BCOR and BCORL1 mRNA in Acute Myeloid Leukemia.
Coskun FR; Percin-Pacal F; Emrence Z; Ar MC; Abaci N; Unuvar A; Eskazan AE; Elverdi T; Salihoglu A; Seflekci Y; Karakas Z; Soysal T; Sirma-Ekmekci S
Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776737
[TBL] [Abstract][Full Text] [Related]
19. OFCD syndrome and extraembryonic defects are revealed by conditional mutation of the Polycomb-group repressive complex 1.1 (PRC1.1) gene BCOR.
Hamline MY; Corcoran CM; Wamstad JA; Miletich I; Feng J; Lohr JL; Hemberger M; Sharpe PT; Gearhart MD; Bardwell VJ
Dev Biol; 2020 Dec; 468(1-2):110-132. PubMed ID: 32692983
[TBL] [Abstract][Full Text] [Related]
20. SWI/SNF Subunits SMARCA4, SMARCD2 and DPF2 Collaborate in MLL-Rearranged Leukaemia Maintenance.
Cruickshank VA; Sroczynska P; Sankar A; Miyagi S; Rundsten CF; Johansen JV; Helin K
PLoS One; 2015; 10(11):e0142806. PubMed ID: 26571505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
